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Expression of iNOS, eNOS and peroxynitrite-modified proteins in
experimental anti-MPO associated necrotizing crescentic glomerulone-
phritis. Nitric oxide radicals are recognized as important mediators in
various physiological and pathophysiological processes. During inflamma-
tion, increased amounts of nitric oxide (NO) are produced, but it is
unclear whether NO radicals are either protective or harmful. To obtain
more insight into the role of NO in glomerular inflammation, we studied
the temporal expression of endothelial NO synthase (eNOS) and inducible
NOS (iNOS) in conjunction with platelet aggregation, inflammatory cell
influx, superoxide anion production cells, and nitrotyrosine formation in
an experimental model of anti-myeloperoxidase (MPO) associated necro-
tizing crescentic glomerulonephritis (NCGN). Brown Norway rats were
immunized with MPO in complete Freund’s adjuvant (CFA) or CFA
alone. After two weeks, the left kidney was perfused with a neutrophil
lysosomal extract and H2O2. Rats were sacrificed at 24 hours, four days,
and 10 days after perfusion. Kidney sections were stained by immunohis-
tochemistry for eNOS, iNOS, platelets, nitrotyrosines, polymorphonuclear
cells (PMN), monocytes, and T-cells. Superoxide anion producing cells
were identified by enzyme cytochemistry using diaminobenzidine. Strong
staining for eNOS was found in glomerular capillaries and interstitial
tubular capillaries and larger vessels from non-perfused kidneys. At 24
hours after perfusion, glomerular and interstitial eNOS staining was
greatly reduced, which was associated with massive platelet aggregation.
At later time points, eNOS expression was absent in severely damaged
glomeruli. Inducible NOS expression was found at all time points in
infiltrating inflammatory cells, which by double labeling studies were
identified as PMNs and monocytes. The peak in iNOS expression was
observed at four days after perfusion but declined thereafter. Superoxide
anion and nitrotyrosine generating cells were also found at all time points,
but were most abundantly present at four days after perfusion, coinciding
with the peak in iNOS expression. Double labeling experiments revealed
that most nitrotyrosine generating cells also produced superoxide anions
and expressed iNOS. In conclusion, these studies suggest that during the
course of anti-MPO associated NCGN, loss of NO production by eNOS in
conjunction with NO radical production by iNOS contribute to tissue
injury. This is compatible with a protective role for eNOS contrasting with
the possibly harmful effects of iNOS in anti-MPO associated NCGN.
Pauci-immune necrotizing crescentic glomerulonephritis
(NCGN) associated with anti-neutrophil cytoplasmic antibodies
(ANCA) is a rapidly progressive form of glomerular disease [1, 2].
Histopathologically, fibrinoid necrosis of the glomerular capillary
wall and marked infiltration of neutrophils and mononuclear cells
sometimes accompanied by granuloma formation are found [3–5].
Deposits of IgG and complement are scarce or absent [3].
Anti-neutrophil cytoplasmic antibodies in ANCA-associated
NCGN are either directed to proteinase 3 or myeloperoxidase
(MPO), which are both myeloid lysosomal enzymes [6–8]. The
close association of ANCA with pauci-immune NCGN suggests a
pathogenic role for these autoantibodies [9]. In vitro, ANCA
activate the respiratory burst and induce degranulation of primed
polymorphonuclear (PMN) leukocytes [10, 11]. To study the
pathogenic potential of anti-MPO antibodies in vivo, our group
previously developed an animal model for anti-MPO associated
NCGN [12]. In this model, proliferative NCGN is induced in
MPO-immunized Brown Norway rats by renal perfusion of PMN
lysosomal enzymes including MPO and its substrate H2O2.
It has long been recognized that activation of PMNs and
monocytes may play an important role in the development of
glomerular capillary wall injury, as seen in NCGN due to the
release of proteolytic enzymes and the generation of reactive
oxygen species (ROS) including superoxide anion [13, 14]. In
addition to ROS, activated PMNs and monocytes are capable of
producing nitric oxide (NO) radicals, which are important medi-
ators in a variety of physiological and pathophysiological pro-
cesses [15, 16]. Initially, NO was described as a vascular relaxing
factor produced by the endothelium [17]. Later studies showed
that NO inhibits platelet aggregation and platelet and leukocyte
adhesion to the endothelium [18]. Also, NO functions as a local
neutrotransmitter and is involved in the antimicrobial and antitu-
moricidal properties of macrophages [16, 18]. Nitric oxide radicals
are synthesized from L-arginine by nitric oxide synthase (NOS) of
which three isoforms can be distinguished: (1) neuronal or brain
NOS (nNOS, type I), (2) inducible NOS (iNOS, type II), and (3)
endothelial NOS (eNOS, type III) [19]. In the kidney, nNOS is
expressed in the macula densa [20]. Endothelial NOS is constitu-
tively expressed by endothelial cells but the expression may be
modulated by shear stress, endothelial cell proliferation and
cytokines [20–22]. Inducible NOS mRNA expression can be
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found in proximal tubules, the cortical and medullary thick
ascending limbs, distal convoluted tubules, and the cortical and
inner medullary collecting ducts of the normal kidney [23]. In
addition, iNOS expression can be induced in several cell types,
including monocytes, neutrophils and mesangial cells, after expo-
sure to cytokines or endotoxin [24, 25].
In inflammatory conditions, excessive amounts of NO are
produced, as has been shown in several experimental models of
immune-mediated glomerulonephritis where increased nitrite/
nitrate concentrations in the urine and increased NO radical
generation by isolated glomeruli were measured [26–28]. In these
models, the increased NO radical production correlates with the
extent of glomerular macrophage influx. Macrophages express the
inducible NOS isoform after cytokine stimulation and exposure to
endotoxin and are capable of generating high amounts of NO for
prolonged periods of time. These studies suggest an important
role for NO radicals in the pathophysiology of glomerulonephritis,
but it is unclear whether NO production is either protective or
harmful [29].
Increased NO radical production during inflammation may be
protective by inhibiting platelet aggregation, thereby preventing
intravascular coagulation and thrombosis. In addition, leukocyte
adhesion to the endothelium may be attenuated and thus reduce
the inflammatory response [30].
In contrast to its beneficial effects, NO radicals may be effector
molecules in the development of tissue injury [18]. Nitric oxide
may inactivate iron-containing enzymes (especially in the mito-
chondria) by reacting with iron to form iron-nitrosyl complexes
resulting in cytotoxicity [31]. Furthermore, the reaction of NO
with superoxide anion (O2
2z) produced by activated inflammatory
cells yields the very reactive compound peroxynitrite (NOz 1 O2
2
3 ONOO2) [32]. Peroxynitrite initiates lipid peroxidation and
induces nitration of tyrosine residues, leading to loss of protein
structure and function [33, 34].
The present study was designed to obtain more insight into the
role of NO radicals in anti-MPO associated NCGN, and to enable
assessment of their potential for therapeutic intervention. To this
end, we studied the temporal expression of iNOS, eNOS and
O2
2z-producing cells in conjunction with the extent of platelet
aggregation, infiltration of inflammatory cells and the formation
of peroxynitrite modified proteins in the rat model of anti-MPO
associated NCGN.
METHODS
Animals
All experiments were performed in conventionally housed,
three-month-old Brown Norway rats (Harlan, Bilthoven, The
Netherlands). Animals were fed ad libitum with standard chow
(Hope Farms, Woerden, The Netherlands).
Neutrophil lysosomal extract
A neutrophil lysosomal extract was prepared as described
previously [12]. Briefly, isolated human polymorphonuclear
(PMN) leukocytes were dissolved in cetylmethyl ammonium
bromide (CETAB; Sigma Chemical Co, St. Louis, MO, USA) and
sonicated. The extract was absorbed to a concanavalin A sepha-
rose gel (Pharmacia, Uppsala, Sweden) and eluted with methyl-
D-mannoside (Sigma). Fractions with an optical density (OD)
428/280 ratio larger than 0.5 were pooled. The resultant eluate
contained mainly MPO and trace amounts of proteinase 3 and
elastase but no lactoferrin, as determined by ELISA.
Isolation of human myeloperoxidase
Human myeloperoxidase was isolated by further purification of
the eluate from the Con A column described above on a Sephadex
G100 gel (Pharmacia). The final human MPO preparation had an
OD 428/280 ratio of 0.82. Gel electrophoresis showed specific
bands for human MPO (at 15, 38, and 58 kDa, data not shown).
Immunization
Brown-Norway rats were immunized with human MPO in
complete Freund’s adjuvant supplemented with H37RA, 5 mg/ml
(Difco). Rats received either 10 mg human MPO or a control
solution (sodium acetate buffer) without human MPO subcuta-
neously in 0.2 ml at two sites near the base of the tail.
Detection of anti-myeloperoxidase antibodies by ELISA
Microtiter plates (Greiner, Kremsmunster, Austria) were
coated for two hours at 37°C with human MPO at a protein
concentration of 2 mg/ml in 0.1 M carbonate buffer, pH 9.6. Plates
were incubated with rat serum, diluted in 0.05 M Tris-HCl, 0.05%
Tween-20, 1% normal goat serum, 2% bovine serum albumin
(BSA), and 0.3 M NaCl, pH 8.0, starting at a dilution of 1:100.
Antibody binding was detected with alkaline phosphatase labeled
goat anti-rat Ig (Cappel Laboratories, West Chester, PA, USA),
followed by p-nitrophenyl phosphate disodium as a substrate. The
plates were read at 405 nm and a standard curve was prepared
from a reference serum. Antibody titers were calculated from the
linearized titration curve of the reference serum. The antibody
titer of the reference serum was set at 100 units.
Perfusion
Two weeks after immunization, an unilateral perfusion of the
left kidney was performed as described previously [12]. Briefly,
left kidneys were perfused with PBS until no visible blood escaped
from the punctured renal vein followed by 0.5 ml (100 mg,
containing 54 mg MPO) of the lysosomal extract. After two
minutes, 2 ml of a 1 mM solution of H2O2 was infused during one
minute. Finally, kidneys were cleared with PBS and the blood flow
was restored. Total ischemia time was always less than 10 minutes.
After surgery, rats were allowed to recover from anesthesia for
two hours under a heat lamp.
Urine analysis
For estimation of proteinuria, urine samples were collected
from all rats in metabolic cages 24 hours after perfusion and
before the day of sacrifice. Proteinuria was determined with the
pyrogallol method.
Nitrite/nitrate assay
Nitrite and nitrate concentrations were measured in serum and
urine samples collected before perfusion, 24 hours after perfusion
and at the time of sacrifice. Nitrite/nitrate concentrations were
measured according to the method of Moshage et al [35].
Histopathology
At the times indicated, kidneys were perfused with PBS at 4°C
to remove the blood. Tissue samples from the left and right kidney
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were obtained and prepared for light microscopy, immunofluo-
rescence, and immunohistochemistry. For light microscopy, renal
tissue was fixed in 4% paraformaldehyde (PFA)/PBS and embed-
ded in paraffin. Two micrometer sections were cut and stained
with hematoxylin eosin (HE). For immunohistology (IF), tissue
samples were snap frozen in isopenthane. Four micrometer
sections were fixed in acetone, except for the incubation with
anti-eNOS and anti-iNOS antibodies for which the sections were
fixed in 4% PFA/PBS. The presence of rat IgG and complement
was determined by immunofluorescence using F(ab)2 goat anti-rat
IgG, and FITC-labeled F(ab)2 goat anti-rat C3 (all from Cappel
Laboratories). As a conjugate FITC-labeled F(ab)2 rabbit anti-
goat was used (Cappel). The amount of rat IgG and complement
was scored on a semiquantitative scale: 0 5 absent; 1 5 weak; 2 5
mild; 3 5 intermediate; 4 5 strong.
Polymorphonucleocytes, monocytes, T-cells and platelets were
detected by an immunoperoxidase staining using the monoclonal
antibodies His48 (PMNs, [36]), ED1 (monocytes, Serotec, Ox-
ford, UK), R73 (T-cells, [37]), and PL-1 [38], followed by perox-
idase (PO) labeled rabbit anti-mouse (Dakopatts, Glostrupp,
Denmark) and aminoethylcarbimazole and H2O2 as a substrate.
Endogenous peroxidase activity was blocked with 0.05% H2O2 in
PBS. Sections were counterstained with hematoxylin. Glomerular
infiltrates were estimated by counting the number of His 48, ED1,
and R73 positive cells within 50 glomeruli and dividing the total by
50. Interstitial infiltrates were quantified on a semiquantitative
scale: 0 5 absent; 1 5 minimal; 2 5 mild; 3 5 moderate; 4 5
severe.
Expression of eNOS was investigated using a mouse monoclo-
nal anti-human eNOS antibody (Transduction Laboratories, Ken-
tucky, USA). The antibody cross-reacts with rat eNOS. By West-
ern blotting on lysates from human endothelial cells a 140 kDa
band was detected. There was no cross-reactivity with nNOS or
iNOS. Binding was detected using a sensitive three-step peroxi-
dase technique, which included sequential incubation with PO-
labeled rabbit anti-mouse, PO-labeled goat anti-rabbit and PO-
labeled rabbit anti-goat antibodies (all from Dakopatts).
Inducible NOS expression was evaluated with a rabbit anti-rat
iNOS antibody [39]. This antibody was raised against a synthetic
peptide corresponding to the C-terminal 14 amino acids 1134 to
1147 of the rat hepatocyte iNOS sequence. By Western blotting,
the antibody recognizes a specific band of 130 to 135 kDa in crude
liver extracts of lipopolysacharide-treated rats. This band was
absent in liver extracts from control rats. Antibody binding was
detected with sequential incubation of PO-labeled goat anti-rabbit
and PO-labeled rabbit anti-goat antibodies (both from Dako-
patts). As a positive control, rat macrophages [40] were stimulated
with LPS (1 mg/ml) for 24 hours and stained in the same way.
Unstimulated macrophages served as a negative control.
To investigate the presence of peroxynitrite modified proteins
an affinity-purified rabbit polyclonal antibody directed against
nitrotyrosine was used (Upstate Biotechnology). By immunohis-
tochemistry, the specificity of the staining was verified by prein-
cubation of the antibody with 10 mM nitrotyrosine/PBS (pH
adjusted to 7.2) for 30 minutes at room temperature.
Sections were counterstained with hematoxylin.
To exclude non-specific binding, additional sections were incu-
bated with rabbit preimmune serum or the primary antibody was
omitted. Glomerular and interstitial expression of iNOS and
nitrotyrosine positive cells was scored as described above for
infiltrating inflammatory cells.
Enzyme cytochemistry for superoxide anion producing cells
Superoxide anion producing cells were detected using enzyme
histochemistry according to the method of Briggs et al [41].
Briefly, sections were fixed in 4% paraformaldehyde in N-2-
hydroxyethyl-piperazine-N9-ethanesulfonic acid (HEPES) buffer
(0.1 M HEPES, 1 mM sodium azide and 5% sucrose in PBS, pH
7.2). Subsequently, sections were incubated in the HEPES buffer
with addition of 4% 3,39-diaminobenzidine (DAB; Sigma) and
625 mM MnCl2 at 37°C for 30 minutes. As a control, additional
sections were stained in the same way in the presence of super-
oxide dismutase. The number of DAB precipitating cells were
counted in 50 glomeruli and are expressed as the mean number of
DAB positive cells per glomerulus. Interstitial DAB precipitating
cells were scored according to the following semiquantative scale:
0 5 absent; 1 5 few; 2 5 mild; 3 5 intermediate; 4 5 many.
Double staining experiments
To identify the cell types expressing iNOS, immunohistochem-
ical double staining was performed. Cryostat sections were incu-
bated with rabbit anti-iNOS followed by PO-labeled swine anti-
rabbit antibodies (Dakopatts). Next, the monoclonal antibody
HIS 48 (rat PMNs) or ED1 (rat monocytes/macrophages) was
applied followed by alkaline phosphatase-labeled goat anti-mouse
antibodies (Dakopatts). The alkaline phosphatase reaction was
developed using a mixture of 0.2 mmol/liter naphtol AS-MX
phophate, 1 mmol/liter fast blue BB salt, and 1 mmol/liter
levamisole (Sigma) in 100 mmol/liter Tris/HCl buffer (pH 8.2) at
37°C for 30 minutes. After extensive washing in PBS, the perox-
idase reaction was developed using aminoethylcarbimazole and
H2O2 as a substrate.
Immunofluorescence double-staining experiments were per-
formed to examine the spatial relationship between the localiza-
tion of iNOS expressing cells and nitrotyrosine formation. In the
first step, cryostat sections were incubated with rabbit anti-iNOS
followed by FITC-labeled F(ab)2 goat anti-rabbit antibody (Da-
kopatts). After extensive washing in PBS, sections were incubated
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Fig. 1. Reactivity of sera from control or myeloperoxidase (MPO)-
immunized Brown Norway rats with purified human MPO. Anti-MPO
titers are expressed as arbitrary units relative to a reference serum that was
set at 100 U.
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with the rabbit anti-nitrotyrosine antibody followed by TRITC-
labeled swine anti-rabbit antibodies (Dakopatts).
Finally, double staining experiments were performed to exam-
ine the spatial relationship between superoxide anion producing
cells and nitrotyrosine deposition. Cryostat sections were enzyme-
cytochemically stained for superoxide anions as described above.
After extensive washing, immunocytochemistry was performed to
detect nitrotyrosines. Sections were incubated with the rabbit
anti-nitrotyrosine antibody followed by alkaline phophatase-la-
beled swine anti-rabbit antibodies (Dakopatts). The alkaline
phosphatase reaction was developed as described above.
Morphometry
Staining intensities for eNOS and platelets were quantified
using morphometrical analysis. Consecutive sections were immu-
nohistochemically stained for eNOS and platelets as described
above. Counterstaining with hematoxylin was omitted. Twenty
glomeruli per rat were evaluated quantitatively by light micros-
copy using computerized image analysis with the Quantimet 600S
(Leica). The amount of reaction product after staining for plate-
lets or eNOS is expressed in units, that is, average optical density
per standard glomerular area [42].
Western blotting
Tissue samples of left and right kidneys were homogenized with
a polytron homogenizer in 20 mM Tris-HCl (pH 7.2) buffer
containing 0.2 mM phenylmethylsulfonyl-fluoride (PMSF), 1 mM
EDTA and 1 mM dithiotreitol. After centrifugation (30 min at
11,600 3 g), the protein concentration in the supernatant was
determined according to Bradford using BSA as the standard. The
crude lysates were run on 10% SDS-PAGE under non-reducing
conditions and transferred to nitrocellulose (Amersham Interna-
tional plc, Buckinghamshire, UK). After blocking in 4% non-fat
skim milk/PBS/Tween-20 (0.1%), blots were incubated with the
rabbit anti-iNOS antibody in PBS/Tween-20 (0.1%). Bound anti-
body was detected with PO-labeled swine anti-rabbit IgG (dilution
1:5000; DAKO A/S, Glostrup, Denmark). The reaction was
visualized with the ECL Western blotting system (Amersham).
Cell lysates from LPS-stimulated rat macrophages served as a
positive control.
Statistical analysis
Values are expressed as mean 6 SD and were analyzed for
statistical differences by the two-tailed Mann-Whitney U-test.
Probability values of , 0.05 were considered significant.
Experimental design
Two experimental groups were formed.
Group 1. Myeloperoxidase animals were immunized with MPO
and perfused with the neutrophil lysosomal extract and H2O2.
Rats were sacrificed at 24 hours (N 5 4), four days (N 5 5) and
10 days (N 5 4) after perfusion.
Group 2. Control animals were immunized with buffer and
perfused with the neutrophil lysosomal extract and H2O2. Rats
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Fig. 2. Urine analysis. (A) Development of proteinuria in control (N 5 6)
or myeloperoxidase (MPO)-immunized (N 5 9) rats at 24 hours, 4 and 10
days after perfusion of the polymorphonuclear (PMN) lysosomal enzyme
extract and H2O2. *P , 0.001, **P , 0.005, compared to values before
perfusion. (B) Urinary excretion of nitrite/nitrate proteinuria in control
(N 5 6) or MPO-immunized (N 5 9) rats at 24 hours, 4 and 10 days after
perfusion of the PMN lysosomal enzyme extract and H2O2. *P , 0.009,
**P , 0.01, compared to values before perfusion. Normal urinary protein
and nitrite/nitrate excretion were estimated in urine samples from all rats
collected prior to perfusion.
Fig. 3. Light microscopy demonstrating lesions found at four days after
perfusion of a PMN lysosomal extract and H2O2 in a myeloperoxidase
(MPO)-immunized rat. Crescent formation, gaps in Bowman’s capsule
and periglomerular and interstitial inflammatory cell infiltration are
observed (methamine-silver staining, 3200).
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were sacrificed at 24 hours (N 5 2), four days (N 5 2) and 10 days
(N 5 2) after perfusion.
RESULTS
Anti-myeloperoxidase response
All rats immunized with human MPO developed antibodies to
human MPO as detected by ELISA (Fig. 1). Sera from control
immunized rats were consistently negative.
Urine analysis
Rats perfused with the lysosomal extract and H2O2 developed
proteinuria during the first 24 hours after perfusion (Fig. 2). No
significant differences were found between MPO and control
immunized rats. At 4 and 10 days after perfusion only slight
proteinuria was detected in both groups.
In MPO and control immunized rats, urinary excretion of
nitrite/nitrate was significantly elevated at 24 hours after perfusion
compared to baseline values (Fig. 2). In MPO immunized rats,
increased urinary nitrite/nitrate levels were still found at day 4 but
returned to normal at day 10 after perfusion.
Histopathology
Anti-myeloperoxidase associated necrotizing crescentic glomerulo-
nephritis. The animal model of anti-MPO associated necrotizing
crescentic glomerulonephritis (NCGN) has been described in
detail previously [12]. Compatible with previous findings, rats
immunized with MPO developed a proliferative crescentic glo-
merulonephritis after unilateral perfusion of the left kidney with a
PMN lysosomal extract, consisting of MPO and proteolytic en-
zymes followed by H2O2, the substrate for MPO. Histologically,
tuft necrosis and accumulation of eosinophilic proteinaceous
material were found at 24 hours. Severe inflammatory lesions
were observed at day 4 and were still present at day 10 after
perfusion (Fig. 3). The lesions at these time points were charac-
terized by fibrinoid necrosis of the glomerular capillary walls,
intra- and extracapillary cell proliferation and crescent formation
in 30 to 80% of the glomeruli (Fig. 3). In the glomeruli as well as
in the interstitium, massive granuloma-like infiltrates of inflam-
matory cells were found mainly consisting of monocytes and
PMNs, accompanied by giant cell formation (Fig. 3 and Table 1).
By immunofluorescence, IgG and C3 were detected along the
glomerular capillary wall at 24 hours after perfusion but were only
weakly present at 4 and 10 days after perfusion.
Expression of endothelial nitric oxide synthase
By immunohistochemistry, strong staining of eNOS was found
in interstitial arteries, peritubular and glomerular capillaries in
renal tissue sections of right non-perfused kidneys of all rats (Fig.
4A). In contrast, interstitial and glomerular eNOS expression was
significantly decreased in tissue sections of the left kidney of
MPO-immunized rats at 24 hours after perfusion of the lysosomal
enzymes and H2O2 (Fig. 4 B, D). Immunohistochemistry for
platelets in consecutive sections revealed that at places where
eNOS expression was absent, massive adhesion and aggregation
of platelets was observed (Fig. 4 C, E). These observations were
confirmed by morphometrical analysis showing a decrease in
glomerular eNOS staining intensity and a strong increase in
glomerular platelets at 24 hours after perfusion (Fig. 5). Four and
10 days after perfusion, glomerular eNOS expression was absent
in severely damaged glomeruli. At these time points only minor
amounts of platelets could be detected. The decrease in eNOS
immunoreactivity in conjunction with platelet aggregation was
also observed in control immunized rats perfused with the lyso-
somal extract and H2O2, although to a lesser extent. At 4 and 10
days eNOS expression appeared normal and no platelet aggrega-
tion was observed.
Expression of inducible nitric oxide synthase
Immunohistochemistry demonstrated strong staining for iNOS
in LPS-stimulated rat macrophages, whereas unstimulated mac-
rophages were negative (Fig. 6 A, B).
In renal tissue sections from the right non-perfused kidney of all
rats weak immunoreactivity for iNOS was found in proximal
tubular epithelial cells (not shown). Glomeruli were negative
except for an occasional positive cell. In MPO-immunized rats
perfused with the neutrophil lysosomal extract and H2O2, strong
expression of iNOS was observed in infiltrating inflammatory cells
at all time points. At 24 hours after perfusion, iNOS positive cells
were found in the interstitium and in glomeruli. At four days, the
number of iNOS positive cells reached its peak (Fig. 6C). At this
time point, iNOS expression was found predominantly in infiltrat-
ing inflammatory cells in the glomeruli whereas only few cells in
the interstitium were positive for iNOS (Fig. 6C). At 10 days after
perfusion, immunoreactivity for iNOS was largely absent (Fig.
6D). Although the number of inflammatory cells is still significant
Table 1. Intraglomerular and interstitial presence of polymorphonucler cells (PMNs), monocytes, and T-cells in experimental anti-mycloperoxidase
(MPO) associated necrotizing crescentic glomerulonephritis
Infiltrating cells Groups
Intraglomerular cells Interstitial cells
24 hours 4 days 10 days 24 hours 4 days 10 days
PMN I 2.2 6 0.8 6.7 6 3.2 3.8 6 2.1 2.0 6 0.5 3.8 6 0.2 2.5 6 0.3
II 1.0 6 0.2 0.7 6 0.3 0.8 6 0.2 0.5 6 0.5 0 0
Monocytes I 1.4 6 0.2 23.1 6 3.8 16.3 6 2.0 2.3 6 0.3 3.4 6 0.2 3.7 6 0.3
II 0.8 6 0.2 1.5 6 0.5 1.8 6 0.3 0 0 0
T cells I 0 1.9 6 0.5 2.5 6 1.0 0 1.8 6 0.4 3.5 6 0.3
II 0 0 0 0 0 0
Group 1 comprised MPO immunized rats perfused with the lysosomal enzyme extract and H2O2. Group 2 were control immunized rats perfused with
the lysosomal enzyme extract and H2O2. Intraglomerular PMNs, monocytes, and T-cells were quantified by counting the number of HIS 48 (PMNs),
ED1 (monocytes) or R73 (T-cells) positive cells in 50 glomeruli and dividing the total by 50. Labeled interstitial cells were scored on a semi-quantitative
scale: 0 5 absent; 1 5 minimal; 2 5 mild; 3 5 moderate; 4 5 severe. Numbers represent mean 6 SD.
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at this time point, only an occasional cell showed iNOS expres-
sion. Double labeling experiments suggested that the inflamma-
tory cells expressing iNOS were HIS 481 PMNs and ED11
monocytes (not shown). In control immunized rats perfused with
the lysosomal extract and H2O2 only few iNOS positive cells were
detected at all time points (Table 2).
Fig. 4. Expression and localization of endothelial nitric oxide synthase
(eNOS) and platelets. (A) Expression and localization of eNOS in renal
tissue of a right non-perfused kidney. Intense immunoreactivity is
observed in glomerular capillaries, tubular capillaries and interstitial
vessels (arrowheads; magnification 3200). (B) Marked reduction of
eNOS expression in a glomerulus at 24 hours after perfusion of the
polymorphonuclear (PMN) lysosomal extract and H2O2 in a
myeloperoxidase (MPO)-immunized rat (3400). (C) The same
glomerulus as in panel B in a consecutive 4 mm section
immunohistochemically stained for platelets. Massive adhesion and
aggregation of platelets in glomerular capillaries is clearly visible. (D)
Expression of eNOS in a small interstitial artery at 24 hours after
perfusion of the PMN lysosomal extract and H2O2 in a MPO-
immunized rat. The eNOS expression is absent in part of the arterial
wall (small arrow; 3400). (E) The same artery as in panel D in a
consecutive 4 mm section immunohistochemically stained for platelets.
Adhesion and aggregation of platelets to the arterial wall is observed at
the site where eNOS expression is absent (small arrow; 3400).
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Western blotting experiments for iNOS showed a strong band
at 130 to 135 kDa in renal cortical tissue homogenates from rats
sacrificed at 24 hours after perfusion, which increased in intensity
at four days and was weak at 10 days (Fig. 6E). The same band was
detected in lysates of LPS stimulated rat macrophages, but no
reactivity was found in cortical tissue homogenates of right
non-perfused kidneys (Fig. 6E).
Expression of superoxide producing cells
Enzyme-cytochemistry revealed the presence of superoxide
anion producing cells at all time points in MPO-immunized rats
perfused with the neutrophil lysosomal extract and H2O2. These
cells were located in the interstitium as well as in the glomeruli.
The number of glomerular superoxide anion-producing cells was
most extensive at four days, coinciding with the peak in iNOS
expressing inflammatory cells, but the number declined thereafter
(Fig. 6F and Table 2). Immunohistochemical double staining
suggested that the superoxide anion-producing cells were ED11
macrophages and HIS481 PMNs (not shown). In the right
non-perfused kidneys and in control immunized rats perfused
with the lysosomal extract and H2O2, only few superoxide anion-
producing cells were found (Table 2).
Generation of peroxynitrite in anti-myeloperoxidase associated
necrotizing crescentic glomerulonephritis
A reaction of NO with superoxide leads to the formation of the
potent oxidant peroxynitrite and may cause nitrotyrosine forma-
tion in proteins. To identify the generation of peroxynitrite in
experimental anti-MPO NCGN, immunohistochemical studies
were performed using a specific antibody directed against nitro-
tyrosines. Intense immunostaining for nitrotyrosines was found in
cells at all time points. These cells were found in the glomeruli,
but the majority were located in the interstitium surrounding
glomeruli and blood vessels (Fig. 7 A, B, and Table 2). As for
iNOS and superoxide anion producing cells, the number of
peroxynitrite generating cells peaked at four days after perfusion.
Preincubation of the antibody with 10 mM 3-nitrotyrosine com-
pletely abolished staining. Immunohistochemical double staining
showed that the majority of nitrotyrosine positive cells also
produced superoxide anions (Fig. 7 C, D) and most cells also
expressed iNOS (Fig. 7 E-G).
DISCUSSION
To obtain better insight into the potential beneficial and/or
harmful role of NO radicals in glomerulonephritis, the production
of NO in concert with the temporal expression of the NOS
isoforms eNOS and iNOS was studied in an experimental model
of anti-MPO associated necrotizing crescentic glomerulonephri-
tis. In this model, enhanced generation of NO was demonstrated
reflected by increased nitrite/nitrate concentrations in the urine.
Immunohistochemistry revealed a marked decrease in eNOS
expression in glomerular capillaries and interstitial vessels after
induction of the disease. At 24 hours, the loss of eNOS was
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Fig. 5. Quantification of glomerular endothelial nitric oxide synthase (eNOS) expression (A) and platelet aggregation (B) 24 hours after perfusion of
the polymorphonuclear (PMN) lysosomal extract and H2O2 using morphometrical analysis in control (N 5 2, M) and myeloperoxidase
(MPO)-immunized (N 5 4, f) rats. Hatched bars represent results obtained from right non-perfused kidneys (N 5 4). Results are expressed in units
(optical density per standard glomerular area) and represent means 6 SD. A. *P , 0.03 compared to right non-perfused kidneys. B. *P , 0.03 and **P ,
0.05 compared to right non-perfused kidneys.
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Fig. 6. Expression and localization of inducible nitric oxide synthase (iNOS) expressing and superoxide anion generating cells. (A) Immunohisto-
chemistry for iNOS on non-stimulated cultured rat macrophages. No iNOS expression is observed (3400). (B) Immunohistochemistry for iNOS on
cultured rat macrophages stimulated with LPS (1 mg/ml) for 24 hours showing intense immunoreactivity for iNOS (3400). (C) Expression and
localization of iNOS in renal tissue from a MPO-immunized rat at four days after perfusion of the PMN lysosomal extract and H2O2. Abundant
expression of iNOS is found in infiltrating PMNs and monocytes in glomeruli while only few interstitial cells express iNOS (3200). (D) Expression and
localization of iNOS in renal tissue from a MPO-immunized rat at 10 days after perfusion of the PMN lysosomal extract and H2O2. Only few cells stain
positive for iNOS (small arrows; 3200). (E) Western blotting for iNOS protein level. Crude lysates (50 mg) were separated on 10% SDS-page,
transferred to nitrocellulose and immunostained with iNOS antiserum. The iNOS antiserum recognized a single protein of approximately 130 to 135
kDa in crude cell extracts of LPS-stimulated rat macrophages (lane F). In renal tissue homogenates from right non-perfused kidneys no
immunoreactivity was found (lane D). Twenty-four hours after perfusion of the PMN lysosomal extract and H2O2 in MPO-immunized rats iNOS protein
was significantly induced (lane A) and increased amounts could be detected at four days after perfusion (lane C). At 10 days after perfusion, iNOS
protein level had declined and was hardly detectable (lane E). Lane B was left empty. (F) Expression and localization of superoxide generating cells.
Intra- and periglomerular presence of superoxide generating cells as detected by enzyme-cytochemistry using diaminobenzidine (3400).
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markedly associated with extensive aggregation and adhesion of
platelets to the endothelium. At later time points, eNOS was
completely absent in severely inflamed glomeruli associated with
massive infiltrates of inflammatory cells. These observations sug-
gest that NO radical production by eNOS have beneficial effects
during inflammation through inhibiting platelet aggregation and
leukocyte adhesion to the endothelium, thereby attenuating the
inflammatory process. Other studies have also suggested an
anti-inflammatory effect of NO. In nephrotoxic nephritis, deple-
tion of circulating L-arginine leads to increased proteinuria and
glomerular thrombosis, whereas the administration of the L-
arginine analog, N-nitro-L-arginine methyl ester (L-NAME), in
LPS-treated rats induces generalized glomerular thrombosis that
can be prevented by treatment with exogenous NO donors
[43–45]. In addition, dietary supplementation of L-arginine inhib-
its atherosclerosis in LDL receptor knock-out mice [46].
The reduction of eNOS expression may be caused by a down-
regulation of the enzyme or may be due to necrosis of endothelial
cells. In pilot experiments in which consecutive sections were
stained for eNOS and rat endothelial cells using the monoclonal
antibody RECA-1 [47], we observed that at places where eNOS
was absent, immunoreactivity for RECA-1 was also lost. Thus,
these preliminary experiments suggest that the reduction of eNOS
expression is due to necrosis of endothelial cells.
The induction of NO radicals has been demonstrated in several
other models of experimental glomerulonephritis by measuring
basal nitrite production by isolated nephritic glomeruli [26–28]. In
all these models a clear correlation was found between the
amount of nitrite generated and the extent of macrophage influx
in the glomeruli, suggesting that macrophages are the main source
for NO. Macrophages isolated from nephritic glomeruli generate
nitrite and depletion of macrophages inhibits ex vivo glomerular
nitrite generation. In a model of acute unilateral immune-complex
glomerulonephritis, immunohistochemistry showed the expres-
sion of iNOS in infiltrating macrophages in nephritic glomeruli
[48]. In the present study, we also demonstrated a marked
induction of iNOS expression in macrophages as well as PMNs in
experimental anti-MPO associated NCGN. The number of iNOS
positive inflammatory cells peaked at day 4 after induction of the
disease and those cells were predominantly localized in the
glomeruli. At 10 days, only few iNOS positive cells were detected
although the number of intraglomerular and interstitial inflam-
matory cells were still considerable at this time point. These
observations suggest that factors responsible for the induction of
iNOS are mainly present in glomeruli and exert their effects
transiently. Transient expression of iNOS has also been observed
in models of experimental pulmonary granulomatous inflamma-
tion induced by intratracheal installation of either zymosan or
silica [49]. In both models, iNOS expression peaked at day 3 after
induction of the models and declined thereafter, while the major-
ity of iNOS expressing inflammatory cells were localized in the
center of the granulomas [50].
The mediators for iNOS expression have not been identified,
but proinflammatory cytokines such as interleukin-1B (IL-1b),
tumor necrosis factor-a (TNF-a) and interferon-g (IFN-g) are
likely to be involved. These cytokines are known to induce or
Table 2. Intraglomerular and interstitial presence of iNOS, superoxide anion, and nitrotyrosine positive cells in experimental anti-MPO associated
crescentic glomerulonephritis
Infiltrating cells Groups
Intraglomerular cells Interstitial cells
24 hours 4 days 10 days 24 hours 4 days 10 days
iNOS positive
cells
I 2.1 6 0.4 9.2 6 1.8 1.3 6 0.6 2.0 6 0.6 1.0 6 0.25 0.3 6 0.3
II 0.5 6 0.2 0.6 6 0.3 0.3 6 0.2 0.5 6 0.5 0 0
Superoxide anion
producing cells
I 1.8 6 0.4 7.3 6 1.4 2.2 6 0.1 0.5 6 0.6 2.6 6 0.9 2.3 6 0.5
II 0.6 6 0.3 0.4 6 0.2 0.4 6 0.3 0 0 0
Nitrotyrosine
positive cells
I 0.2 6 0.1 1.2 6 0.3 0.4 6 0.1 1.3 6 0.3 1.6 6 0.5 1.5 6 0.6
II 0.2 6 0.05 0.05 6 0.1 0.2 6 0.05 0 0 0
Group 1 comprised MPO Immunized rats perfused with the lysosomal enzyme extract and H2O2. Group 2 were control immunized rats perfused with
the lysosomal enzyme extract and H2O2. Intraglomerular iNOS positive, superoxide anion producing, and nitrotyrosine positive cells were quantified
by counting the number of rabbit anti-iNOS, DAB, and rabbit anti-nitrotyrosine positive cells in 50 glomeruli and dividing the total by 50. Labeled
interstitial cells were scored on a semiquantitative scale: 0 5 absent; 1 5 minimal; 2 5 mild; 3 5 moderate; 4 5 severe. Numbers represent mean 6
SD.
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Fig. 7. Expression and localization of nitrotyrosines. (A) Intense immunoreactivity for nitrotyrosines in intraglomerular and interstitial cells in renal
tissue of a myeloperoxidase (MPO)-immunized rat at four days after perfusion of the PMN lysosomal extract and H2O2. Most nitrotyrosine positive cells
are located in the interstitium (3200). (B) Intra- and periglomerular presence of nitrotyrosine positive cells in renal tissue of a MPO-immunized rat
at four days after perfusion of the PMN lysosomal extract and H2O2 (3200). (C and D) Colocalization of nitrotyrosine and superoxide anion generating
cells in renal tissue of a MPO-immunized rat at four days after perfusion of the PMN lysosomal extract and H2O2. Kidney sections were
immunohistochemically stained for nitrotyrosines using an alkaline-phosphatase labeled conjugate (C and D, blue staining). Next, superoxide anion
generating cell were enzyme-cytochemically identified using diaminobenzidine (D, brown staining). For comparison, a single alkaline-phophatase
staining for nitrotyrosine is also shown in panel C (C and D 3400). (E, F and G) Co-localization of nitrotyrosine generating and iNOS expressing cells
in renal tissue of a MPO-immunized rat at four days after perfusion of a PMN lysosomal extract and H2O2 by immunofluorescence. Most cells are
positive for iNOS (E, green fluorescence) and nitrotyrosine (F, red fluorescence). In panel G, dual immunofluorescence labeling is shown, cells positive
for iNOS and nitrotyrosine stain orange. Arrowheads indicate cells only expressing iNOS (E, F and G, 3400).
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potentiate iNOS expression in vitro and, previously, their presence
in anti-MPO associated NCGN has been demonstrated [25, 50].
The abundant expression of iNOS together with its capacity to
generate large quantities of NO for prolonged periods of time
suggests an important role for iNOS in the pathophysiology of
experimental anti-MPO associated NCGN. High levels of NO
may be cytostatic or cytotoxic by binding of NO to iron-sulphur
containing enzymes, particularly those of the mitochondrial elec-
tron transport chain [31]. Nitric oxide may also react with
superoxide anions to form peroxynitrite, a potent oxidant capable
of initiating lipid peroxidation and inducing nitration of tyrosine
residues in proteins [32–34]. In the present study, large numbers
of superoxide producing inflammatory cells were demonstrated by
enzyme cytochemistry coinciding with the peak of iNOS expres-
sion. Subsequent immunostaining with an anti-nitrotyrosine spe-
cific antibody showed intense immunoreactivity for nitrotyrosine
in cells predominantly located in the interstitium. In addition,
double staining experiments revealed that most nitrotyrosine
positive cells also produced superoxide and expressed iNOS.
Taken together, these observations support a role for NO radicals
as effector molecules contributing to tissue damage during the
course of anti-MPO associated NCGN. As such, blocking NO
radical production derived from iNOS may be beneficial during
inflammation by preventing NO-radical mediated tissue damage.
Recently, Narita et al found that in the anti-Thy-1 model admin-
istration of the NOS inhibitor L-NMMA or restriction of dietary
L-arginine prevented mesangial cell lysis by 90% [51]. In addition,
selective knock-down of iNOS by oligodeoxynucleotide strategy
protected rats from renal ischemia/reperfusion injury [52].
In conclusion, these studies suggest that NO radical production
is an important event during the course of experimental anti-MPO
associated NCGN and may be a target for therapeutic interven-
tion. In this respect, it is important to note that our studies also
suggest that NO during inflammation may be protective as well as
detrimental, depending on the NOS isoform generating the NO
radicals. Nitric oxide synthesized by eNOS may have anti-inflam-
matory effects through inhibition of platelet aggregation and
leukocyte adhesion to the endothelium. Loss of eNOS will lead to
intravascular thrombosis and leukocyte infiltration thereby exac-
erbating inflammation. Thus, compensation of the eNOS-medi-
ated NO radical production by, for example, administration of
exogenous NO donors, may be of therapeutic value. In contrast,
NO generated by iNOS may be harmful because it induces
cytotoxicity and thereby contributes to tissue damage. Therefore,
inhibition of iNOS activity may be beneficial as it reduces NO
radical-mediated tissue injury.
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APPENDIX
Abbreviations used in this article are: ANCA, anti-neutrophil cytoplas-
mic antibodies; BSA, bovine serum albumin; CFA, complete Freund’s
adjuvant; DAB, 3,39-diaminobenzidine; eNOS, endothelial nitric oxide
synthase; HE, hematoxylin eosin; IF, immunohistology; IL-1B, interleu-
kin-1beta; iNOS, inducible nitric oxide synthase; IFN-g, interferon gam-
ma; LPS, lipopolysaccharide; L-NAME, L-arginine analog N-nitro-L-
arginine methyl ester; MPO, myeloperoxidase; NCGN, necrotizing
crescentic glomerulonephritis; NO, nitric oxide; nNOS, neuronal or brain
nitric oxide synthase; O2
2z, superoxide anion; PFA, paraformaldehyde;
PBS, phosphate buffered saline; PMN, polymorphonuclear cells; PMSF,
phenylmethylsulfonyl-fluoride; PO, peroxidase; ROS, reactive oxygen
species; TNF-a, tumor necrosis factor alpha.
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